日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multi-Omics and Machine Learning-Uncovered FLT1-Mediated Epithelial-Endothelial Crosstalk in Cellular Senescence Driving Clear Cell Renal Cell Carcinoma Malignancy.

多组学和机器学习揭示了FLT1介导的上皮-内皮细胞串扰在细胞衰老中驱动透明细胞肾细胞癌恶性转化。

Sun Mouyuan, Mao Huchao, Luo Yaxian, Yang Mei, He Zhixu, Li Shuangyang, Liu Zhichao, Peng Lianjie, Zhang Quanjie, Zhang Jingyu, Zhang Yan

Approved trends and product characteristics of digital therapeutics in four countries

四个国家数字疗法的批准趋势和产品特性

Liang, Jun; Fang, Qichuan; Jiao, Xiaoyi; Xiang, Peng; Ma, Junhao; Zhang, Zijiao; Liu, Yongcheng; He, Yunfan; Li, Yingjun; He, Zhixu; Lei, Jianbo

Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapy

基于集成微流控技术的抗BTN2A2凝胶液滴细胞制剂构建方法,用于非侵入性肿瘤浸润淋巴细胞治疗

Tian, Yishen; Li, Jingxuan; Yang, Na; Zhao, Yang; Zuo, Jiancao; Xiong, Hang; Pan, Yiwen; Xiao, Li; Su, Min; Han, Feng; He, Zhixu; Hu, Rong

Parabacteroides as a promising target for disease intervention: current stage and pending issues

拟杆菌作为疾病干预的潜在靶点:现状及待解决的问题

Liu, Jing; Qiu, Hui; Zhao, Jiamin; Shao, Nan; Chen, Chao; He, Zhixu; Zhao, Xu; Zhao, Juanjuan; Zhou, Ya; Xu, Lin

Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells

CD19 CAR T 细胞治疗淋巴瘤患者心血管毒性风险分析

Liu, Yang; Yuan, Xiaoshuang; Yang, Xu; Yang, Bo; Liu, Guangyang; Xu, Xiao; Wang, Sanbin; He, Zhixu; Wang, Feiqing; Li, Yanju

Effects of mesenchymal stem cells from different sources on the biological functions of multiple myeloma cells

不同来源间充质干细胞对多发性骨髓瘤细胞生物学功能的影响

Li, Yanju; Liu, Yang; Yang, Xu; Yang, Bo; Cheng, Jinyang; Chen, Juan; Yuan, Xiaoshuang; Xu, Xiao; Liu, Guangyang; He, Zhixu; Wang, Feiqing

Exosomal non-coding RNAs: mediators of crosstalk between cancer and cancer stem cells

外泌体非编码RNA:癌细胞与癌症干细胞之间相互作用的介质

Wang, Shuangmin; Shu, Jiaojiao; Wang, Nuoxin; He, Zhixu

The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative splicing of ZMYND8.

RBM39 降解剂 indisulam 通过改变 ZMYND8 的选择性剪接来抑制急性巨核细胞白血病

Yang Ying, Li Zhiheng, Yang Yang, Xiao Peifang, He Zhixu, Zhang Zimu, Li Yizhen, Shi Lei, Wang Xiaodong, Tao Yanfang, Fan Junjie, Zhang Fenli, Yang Chunxia, Yao Fahua, Ji Tongting, Zhang Yongping, Zhou Bi, Yu Juanjuan, Guo Ailian, Wei Zhongling, Jiao Wanyan, Wu Yumeng, Li Yan, Wu Di, Wu Yijun, Gao Li, Hu Yixin, Pan Jian, Hu Shaoyan, Yang Xiaoyan

Identification and validation of ARF6 for a potential prognostic biomarker of acute myeloid leukemia

鉴定和验证 ARF6 作为急性髓系白血病的潜在预后生物标志物

Zhang, Chike; Liu, Yang; Yuan, Xiaoshuang; Yang, Xu; Yang, Bo; Huang, Yi; Wang, Feiqing; He, Zhixu; Li, Yanju

Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies

CD19联合CD22或CD20嵌合抗原受体T细胞疗法治疗血液系统恶性肿瘤的疗效和安全性

Yuan, Xiaoshuang; Wang, Feiqing; Zhao, Peng; Yang, Bo; Yang, Xu; Tian, Ting; Li, Bingbing; Liu, Guangyang; Wang, Sanbin; Tang, Dongxin; He, Zhixu; Li, Yanju; Liu, Yang